Cannabis: Where the Benefits Are Real, and Where the Risks Still Matter
A clinical look beyond the headlines — for patients facing cancer, trauma, and the toll of hard physical work
Most of what the public hears about cannabis falls into one of two camps: it’s either a dangerous drug or a harmless cure-all. Neither is accurate. As an integrative psychiatrist, I look at the actual clinical literature, and it tells a more useful story — cannabis has genuine, well-documented benefits for specific symptoms in specific people, alongside real risks that matter a great deal depending on who’s using it and what they do for a living.
“James,” a 44-year-old ironworker, came to see me after years of chronic shoulder and lower back pain from decades on structural steel. He’d cycled through opioids, anti-inflammatories, and two surgeries. He’d also started using cannabis on weekends, off the job, and reported it helped him sleep and eased pain his other medications hadn’t touched — but he was candid that he’d never use it before a shift 400 feet up. That distinction, using it for recovery rather than for function during high-risk work, is exactly where the evidence points.
Cancer: The Strongest Evidence Base
This is where cannabis has the most rigorous support. Synthetic cannabinoids — dronabinol and nabilone — are FDA-approved specifically for chemotherapy-induced nausea and vomiting that hasn’t responded to standard antiemetics, and for appetite stimulation in cancer-related wasting. Whole-plant cannabis is used off-label for the same purposes, along with cancer pain, with observational data generally supporting benefit for nausea, appetite, and sleep during treatment. This is the one area where “cannabis helps” is closest to a settled clinical fact rather than an open question.
PTSD: Promising, But Genuinely Mixed
This is the area most misrepresented in both directions. A 2015 randomized trial of nabilone (synthetic THC) in military personnel found meaningful reductions in trauma-related nightmares and better sleep. A more recent trial comparing THC, CBD, and combination products against placebo found some formulations outperformed placebo on PTSD symptoms. Sleep disruption, nightmares, and hyperarousal appear to be the symptom clusters most likely to respond.
But the picture isn’t uniformly positive. A 10-year longitudinal study of over 2,000 veterans found that those using cannabis to self-treat PTSD had worse symptom severity over time, along with increases in violent behavior and other substance use, compared to those who didn’t. Several reviews note that people with more severe PTSD are more motivated to use cannabis to cope — which makes it hard to know whether cannabis is helping or simply being used more by people who are struggling more. Chronic, daily use in particular has been linked to worse long-term outcomes even when short-term relief is real. The honest clinical read: cannabis may meaningfully help specific symptoms like nightmares and sleep in some individuals, especially with lower-THC or nabilone-type products, while daily heavy use can worsen the underlying disorder over time.
Physically Demanding Work: Construction, Commercial Fishing, Ironworking
People in physically punishing trades carry an enormous cumulative pain burden — degenerative joints, chronic musculoskeletal injury, nerve damage. Clinical reviews of cannabis for chronic pain show moderate-quality evidence of benefit, particularly for neuropathic pain and fibromyalgia, with one 12-week trial finding over half of participants on THC-containing formulations reported significant pain relief. Economic research has even found that after states legalized recreational cannabis, older workers with chronic pain showed measurable improvements in work capacity.
Why the Job Matters as Much as the Diagnosis
This is the piece that gets lost in most articles on cannabis benefits: the same drug that helps someone sleep or manage chronic pain at home can impair judgment, reaction time, and coordination during a shift. For a commercial fisherman on a moving deck, a construction worker on scaffolding, or an ironworker walking steel at height, that impairment isn’t a minor tradeoff — it’s the difference between a normal day and a fatality. Workplace safety reviews consistently flag cannabis-related sedation and impaired coordination as real occupational hazards, and this is exactly why “does it help” and “should you use it on the job” are two completely different questions with two different answers.
The Bottom Line
| Condition | Evidence Strength | Best-Supported Use |
|---|---|---|
| Chemo-related nausea/appetite | Strong (FDA-approved synthetics) | During active cancer treatment |
| PTSD (nightmares, sleep) | Moderate, mixed | Lower-dose or nabilone; caution with heavy daily use |
| Chronic occupational pain | Moderate | Off-shift recovery, not on-the-job use |
Cannabis isn’t a villain, and it isn’t a miracle. It’s a pharmacologically active substance with real, condition-specific benefits and real, dose- and context-dependent risks. The right question for any individual patient isn’t “is cannabis good or bad” — it’s whether it fits their specific symptoms, their specific job, and their specific risk profile, ideally worked out with a physician who can weigh all three.
Keywords: medical cannabis benefits, cannabis for PTSD, cannabis chemotherapy nausea, cannabis chronic pain, medical marijuana for veterans, cannabis and workplace safety, integrative psychiatry Palm Beach, young adult mental health Florida
#MedicalCannabis #PTSDTreatment #ChronicPainRelief #IntegrativePsychiatry #CancerSupportiveCare #MentalHealthFlorida #DrMarkAgresti
Considering Medical Cannabis as Part of Your Treatment Plan?
Dr. Mark G. Agresti, MD offers integrative psychiatric care for young adults, addiction medicine, and complex mental health conditions — in person in Palm Beach or via telemedicine anywhere in Florida.
Mark G. Agresti MD LLC 44 Cocoanut Row, Suite M202, Palm Beach, FL 33480 Phone: [(561) 760-4107](tel:(561) 760-4107) | Email: [email protected] DrMarkAgresti.com
- Selected references:
- Jetly R, et al. (2015). Nabilone for PTSD nightmares — randomized controlled trial.
- Wilkinson ST, et al. (2015). 10-year longitudinal outcomes of cannabis use in veterans with PTSD.
- LaFrance EM, et al. (2021). Cannabis in the management of PTSD: a systematic review.
- Notcutt W, et al. Randomized crossover trial of THC/CBD for chronic musculoskeletal pain.
- NCBI/CADTH (2019). Medical Cannabis for the Treatment of Chronic Pain: Review of Clinical Effectiveness and Guidelines.
- Medicinal Cannabis and Implications for Workplace Health and Safety: Scoping Review (2023).